Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Lumbrokinase is a complex of fibrinolytic serine proteases derived primarily from *Lumbricus rubellus* earthworms. It supports cardiovascular health by directly breaking down fibrin clots and indirectly promoting natural clot dissolution through tPA activation.
Reported Benefits (Provisional)
Origin & History
Lumbrokinase is a potent fibrinolytic enzyme complex (EC 3.4.21.x) isolated from the earthworm *Lumbricus rubellus*. Renowned for its ability to hydrolyze fibrin, it effectively dissolves blood clots and improves microcirculation, supporting overall cardiovascular and vascular health. This enzyme is widely utilized in supplements for its natural thrombolytic and anti-inflammatory properties.
Research Narrative (Provisional)
Numerous in vitro, animal, and human clinical studies, including randomized controlled trials, have investigated lumbrokinase's fibrinolytic and anti-thrombotic properties. Research supports its potential in managing cardiovascular conditions, improving blood rheology, and enhancing cerebral circulation, though more large-scale human trials are ongoing to solidify specific therapeutic guidelines.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Proteolytic enzyme complex (serine proteases) - Specific activity: Fibrinolytic (hydrolyzes fibrin and fibrinogen) - Molecular weight: Comprises multiple isoenzymes (e.g., 25-30 kDa)
Reported Mechanism (Provisional)
Lumbrokinase, a complex of serine proteases, acts through direct and indirect fibrinolysis. It directly degrades fibrin, including both plasminogen-rich and plasminogen-free forms, and indirectly enhances endogenous fibrinolysis by promoting tissue plasminogen activator (tPA) activity to convert plasminogen to plasmin. This action selectively targets existing fibrin, improving blood rheology.
Clinical Narrative (Provisional)
Extensive research, including numerous in vitro, animal, and human clinical studies, particularly randomized controlled trials, has investigated lumbrokinase. These studies demonstrate its fibrinolytic and anti-thrombotic properties. Outcomes suggest its potential in managing various cardiovascular conditions, improving blood rheology, and enhancing cerebral circulation. However, further large-scale human trials are ongoing to fully establish its therapeutic efficacy and safety profile across diverse populations.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.